The disease-free survival rates of patients with stage I-III cancer and the overall survival rates of patients with stage IV cancer were shorter in patients with low TOP1MT expression than those in patients with high TOP1MT expression (Fig. 6C and D). The gene discussed is TOP1MT; the disease is cancer.